Company intelligence
ONL Therapeutics
Helping patients see the future
Biotechnology Research
Ann Arbor, US
38 employees
Founded 2011
1 public signals
About ONL Therapeutics
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease. By advancing a breakthrough technology designed to protect key retinal cells from Fas-mediated cell death, ONL is pioneering a new approach to preserving vision. ONL is developing a platform of products for use in a range of blinding diseases, including age-related macular degeneration, retinal detachment, glaucoma, and inherited retinal disease.
Verified activity
Signals from ONL Therapeutics
1 published signal